Australian farmer Nando Maisano used the weed killer Roundup since 1976 to clear his properties of thistle and weeds. Sometimes he wore gloves or a mask when he sprayed, but he never worried about it harming him, even when he became drenched in the herbicide, because he believed it to be “safer than table salt.”
In 1997, Maisano was diagnosed with non-Hodgkin’s lymphoma. Still under the impression Roundup was safe, he continued to use it at his Melbourne home until 2018. Then he learned that glyphosate, the active ingredient in Roundup, had been linked to cases of non-Hodgkin’s lymphoma, and that the World Health Organization’s International Agency for Research on Cancer had listed glyphosate as a probable carcinogen. Now he is seeking justice.
Maisano is the lead plaintiff among about 100 in a major class action lawsuit filed in Supreme Court of Victoria against Bayer AG, German-based pharmaceutical giant that acquired Monsanto last year. His lawsuit accuses Bayer and Monsanto of ignoring evidence that the weed killer could cause cancer, and failing to warn consumers of the risk. As a result, Maisano suffered permanent medical and psychological damage.
Bayer faces more than 42,000 Roundup lawsuits in the United States. Three cases have gone to trial to date, all of which have resulted in multi-million-dollar verdicts in favor of the plaintiffs, including $2.055 billion to an elderly California couple who both developed non-Hodgkin’s lymphoma after years of using Roundup on their property.
Roundup is still widely used around the world. However, in recent years, due to heightened safety concerns, Germany, Austria, France and Thailand have made efforts either to ban or dramatically curtail use of the herbicide.
Beasley Allen is investigating cases involving non-Hodgkin’s lymphoma related to the commercial application of Roundup/glyphosate. For more information or to discuss a possible claim, contact John Tomlinson, Danielle Ingram, Michael Dunphy or Rhon Jones.